Needham & Company Maintains a 'Buy' on Medidata Solutions (MDSO); Favorable Demand Environment
Tweet Send to a FriendGet Alerts MDSO Hot Sheet
Price: $74.10 +2.62%
Rating Summary:
7 Buy, 3 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 12 | New: 30
Rating Summary:
7 Buy, 3 Hold, 1 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 8 | Down: 12 | New: 30
Trade MDSO Now!
Needham & Company maintains a 'Buy' on Medidata Solutions (NASDAQ: MDSO) price target raised from $30 to $35.
Analyst, Michael Huang, said, "MDSO’s Q1 call was highlighted by accelerating app revenue growth, raised revenue/EPS guidance, more multi-product deals, a strong pipeline, and competitive takeaways. We were particularly impressed that roughly 25% of new customers purchased more than one product (vs. single digit % a year ago), which we believe reflects the credibility of MDSO’s broader platform and product cycles...We are buyers of MDSO given valuation that we see as favorable (2.9x EV/12Revs) and accelerating trends."
FY12 EPS estimate cut from $1.28 to $1.12 and FY13 from $1.56 to $1.49.
For an analyst ratings summary and ratings history on Medidata Solutions click here. For more ratings news on Medidata Solutions click here.
Shares of Medidata Solutions closed at $28.64 yesterday, with a 52 week range of $14.07-$29.65.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
Analyst, Michael Huang, said, "MDSO’s Q1 call was highlighted by accelerating app revenue growth, raised revenue/EPS guidance, more multi-product deals, a strong pipeline, and competitive takeaways. We were particularly impressed that roughly 25% of new customers purchased more than one product (vs. single digit % a year ago), which we believe reflects the credibility of MDSO’s broader platform and product cycles...We are buyers of MDSO given valuation that we see as favorable (2.9x EV/12Revs) and accelerating trends."
FY12 EPS estimate cut from $1.28 to $1.12 and FY13 from $1.56 to $1.49.
For an analyst ratings summary and ratings history on Medidata Solutions click here. For more ratings news on Medidata Solutions click here.
Shares of Medidata Solutions closed at $28.64 yesterday, with a 52 week range of $14.07-$29.65.
Join StreetInsider.com FREE and get immediately alerted when news breaks on your stocks and other market items - JOIN NOW
*NEW - Download StreetInsider's FREE iPhone and iPad App - Click Here
You May Also Be Interested In
- Morgan Stanley Maintains Bullish Stance on Walter Energy (WLT)
- Wells Fargo Upgrades Tibco Software, Inc. (TIBX) to Outperform; Near a Bottom
- Deutsche Bank Sees Upside in AIG (AIG) Stock
Create E-mail Alert Related Categories
Analyst Comments, Analyst EPS Change, Analyst EPS View, Analyst PT ChangeRelated Entities
Needham & Company
Login with Facebook
Sign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
